Marco Biolato Selected Research

Marco Biolato Research Topics

Disease

8	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 08/2013
5	Neoplasms (Cancer) 09/2021 - 02/2013
4	Hepatitis 01/2024 - 06/2009
4	Liver Cirrhosis (Hepatic Cirrhosis) 05/2023 - 06/2019
4	Fibrosis (Cirrhosis) 11/2022 - 01/2018
4	Non-alcoholic Fatty Liver Disease 10/2020 - 10/2009
3	Thrombosis (Thrombus) 04/2022 - 08/2013
2	Thrombocytopenia (Thrombopenia) 11/2022 - 01/2022
2	Liver Diseases (Liver Disease) 04/2022 - 10/2009
2	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2015
1	Starvation 01/2024
1	Hypophosphatemia 01/2024
1	Hypothermia 01/2024
1	Hypotension (Low Blood Pressure) 01/2024
1	Chemical and Drug Induced Liver Injury 01/2024
1	Hypokalemia 01/2024
1	Sarcopenia 05/2023
1	Hepatic Encephalopathy 05/2023
1	Autoimmune Hepatitis 01/2021
1	Relapsing-Remitting Multiple Sclerosis 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Disease Progression 01/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Cholecystitis 06/2019
1	Ascites 06/2019
1	Overweight 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Abdominal Obesity 01/2019
1	Multiple Sclerosis 01/2018
1	Hepatitis C 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 03/2015
1	Chronic Hepatitis C 11/2013
1	Chronic Hepatitis B 11/2013
1	Atrophic Gastritis 02/2013
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2013
1	Diarrhea 02/2013
1	Peptic Ulcer (Peptic Ulcers) 02/2013
1	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 02/2013
1	Metaplasia 02/2013
1	Abdominal Pain (Pain, Abdominal) 12/2009
1	Adenocarcinoma 12/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2009
1	Hypercholesterolemia 06/2009

Drug/Important Bio-Agent (IBA)

4	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 08/2013
2	Transaminases (Aminotransferases)IBA 01/2024 - 01/2019
2	daclatasvirIBA 01/2019 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	Antidepressive Agents (Antidepressants)IBA 01/2024
1	Antipsychotic Agents (Antipsychotics)IBA 01/2024
1	Amino Acids FDA Link 05/2023
1	Branched-Chain Amino AcidsIBA 05/2023
1	lusutrombopagIBA 11/2022
1	Vitamin K FDA Link 04/2022
1	AnticoagulantsIBA 04/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2022
1	avatrombopagIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 09/2021
1	teriflunomideIBA 01/2021
1	Alemtuzumab (Campath)FDA Link 01/2021
1	Cladribine FDA LinkGeneric 01/2021
1	Dimethyl FumarateIBA 01/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021
1	ocrelizumabIBA 01/2021
1	Interferon-betaIBA 01/2021
1	Natalizumab (Tysabri)FDA Link 01/2021
1	Glatiramer Acetate (Copaxone)FDA Link 01/2021
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 10/2020
1	degradable starch microspheresIBA 03/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	FructoseIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	SofosbuvirIBA 01/2018
1	Methylprednisolone FDA LinkGeneric 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Ribavirin (Virazole)FDA LinkGeneric 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 03/2015
1	SodiumIBA 07/2014
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2014
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2014
1	Alkaline PhosphataseIBA 07/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013
1	Sunitinib (Sutent)FDA Link 08/2013
1	GastrinsIBA 02/2013
1	Intrinsic Factor FDA Link 02/2013
1	AcidsIBA 02/2013
1	AntibodiesIBA 02/2013
1	Analgesics (Analgesic Drugs)IBA 12/2009
1	Ethanol (Ethyl Alcohol)IBA 10/2009
1	Methotrexate (Mexate)FDA LinkGeneric 10/2009
1	LipidsIBA 06/2009

Therapy/Procedure

8	Liver Transplantation 11/2023 - 05/2017
7	Therapeutics 04/2022 - 06/2009
3	Drug Therapy (Chemotherapy) 03/2019 - 10/2009
2	Transplantation 12/2021 - 05/2017
1	Contraindications 03/2019
1	Mediterranean Diet 01/2019
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2019
1	Adjuvant Radiotherapy 03/2015
1	Pancreaticoduodenectomy 12/2009
1	Complementary Therapies (Alternative Medicine) 06/2009